Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Earnings Results, Misses Estimates By $0.02 EPS
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) announced its quarterly earnings data on Monday. The biotechnology company reported ($0.74) EPS for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.02), Briefing.com reports. During the same quarter in the previous year, the firm earned ($0.82) EPS. Rocket Pharmaceuticals Price Performance NASDAQ:RCKT opened at $20.13 on […]
More Stories
White House Pushes Back Against Recession Speculation as Stock Market Drops
By Jack Phillips A top White House economic adviser pushed back against talk of a U.S. recession amid uncertainty on...
Dow Plunges Nearly 900 Points, Nasdaq in Correction Territory as Recession Fears Build
By Andrew Moran Wall Street navigated a fresh round of turbulence to kick off the trading week after President Donald...
Zelenskyy Apologized to Trump After Oval Office Clash, Witkoff Says
By Tom Ozimek Ukrainian President Volodymyr Zelenskyy apologized to President Donald Trump for a heated Oval Office meeting this past...
Trump Confirms Ongoing Talks With 4 Bidders for Potential TikTok Sale
By Bill Pan The Trump administration is actively negotiating with four parties interested in purchasing TikTok from its Chinese parent...
High-Dose Vitamin D May Slow Progression of MS-Like Neurological Disorder
By George Citroner A new clinical trial has found that high doses of vitamin D may significantly slow the progression...
Afghanistan: Top UN envoy calls for ‘a moment of realism’, as Taliban’s isolation grows
The top UN envoy for Afghanistan on Monday underscored the need for realistic engagement with the country as humanitarian and...